ASCP Annual Meeting
Avance Clinical will attend the ASCP Annual Meeting from May 26-29, 2026, in Miami Beach, Florida.
Search results
We found 173 results for: “phase ii”
Oncology Center of Excellence: Biotech Mix & Mingle – Meet the Experts
An informal evening for emerging biotech leaders exploring early phase clinical development opportunities in the U.S. and Australia.
BIO CHINA 2026
Avance Clinical, a full‑service CRO with more than 30 years of experience, will attend BIO CHINA 2026, a premier gathering of global biotech innovators and scientific leaders.
Mandip Gill
Dr Mandip Gill is a Site Specialist at Avance Clinical based in Melbourne, Victoria, Australia. A scientist by training with a PhD in Human Genetics, she brings over seven years of experience across Phase I–III oncology and haematology trials, including solid tumours, lymphomas, and leukaemias ...
CKD Summit 2026
Avance Clinical will attend the CKD Summit 2026, March 16–18 in Boston, a leading global forum focused on accelerating innovation in chronic kidney disease.
AD/PD™ 2026 Alzheimer’s & Parkinson’s Diseases Conference
Avance Clinical will attend AD/PD 2026 from March 17-21, 2026, in Copenhagen, Denmark.
Dalal Murgai
As the Senior Vice President of Global Regulatory Affairs for Scientific, Regulatory & Medical Affairs in North America, Dalal Murgai provides strategic leadership for Regulatory Operations across the region. She serves as an executive sponsor to biotech clients, shaping IND‑enabling strategy, pragmatic study design, and ...
Why Early CRO Choice Is Critical To Accelerating Delivery Of Your Clinical Program
Australia's pragmatic regulatory environment, accelerated timelines, globally accepted data, Research and Development Tax Incentive, and other advantages, have emerged as a compelling strategy for Phase I trials.
BIO-Europe Spring 2026
Avance Clinical is excited to be attending BIO-Europe Spring 2026, taking place in Lisbon, Portugal from 23–25 March 2026.
AACR Annual Meeting 2026
Meet Avance Clinical at the AACR Annual Meeting 2026 in San Diego.